The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inhalational Anaesthesia Drugs Market Research Report 2025
Synopsis
Inhalational anaesthesia drugs, ether and halothane were more commonly used in the past, and sevoflurane, desflurane, and isoflurane are more commonly used. Inhaled anesthetics can enter the lungs through the patient's respiratory tract, diffuse into the capillaries, and then enter the body's circulatory system and central nervous system. For inhalational anaesthesia drugs, professional equipment should be used. The patient can make the pain and consciousness disappear within a few minutes after the inhalation anesthesia, so that the operation can proceed smoothly. After stopping the medication, the patient can quickly regain self-awareness. Inhaled anesthetics are characterized by strong controllability and high safety, and they are a common method of anesthesia used in clinical practice.
The global Inhalational Anaesthesia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Inhalational Anaesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalational Anaesthesia Drugs.
Report Scope
The Inhalational Anaesthesia Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhalational Anaesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalational Anaesthesia Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
Baxter
Hikma Pharmaceuticals PLC
Halocarbon Products Corporation
Piramal Enterprises Limited
Lunan Pharmaceutical Group Co. Ltd.
Segment by Type
Enflurane
Isoflurane
Halothane
Sevoflurane
Atropine
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhalational Anaesthesia Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Inhalational anaesthesia drugs, ether and halothane were more commonly used in the past, and sevoflurane, desflurane, and isoflurane are more commonly used. Inhaled anesthetics can enter the lungs through the patient's respiratory tract, diffuse into the capillaries, and then enter the body's circulatory system and central nervous system. For inhalational anaesthesia drugs, professional equipment should be used. The patient can make the pain and consciousness disappear within a few minutes after the inhalation anesthesia, so that the operation can proceed smoothly. After stopping the medication, the patient can quickly regain self-awareness. Inhaled anesthetics are characterized by strong controllability and high safety, and they are a common method of anesthesia used in clinical practice.
The global Inhalational Anaesthesia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Inhalational Anaesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalational Anaesthesia Drugs.
Report Scope
The Inhalational Anaesthesia Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhalational Anaesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalational Anaesthesia Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
Baxter
Hikma Pharmaceuticals PLC
Halocarbon Products Corporation
Piramal Enterprises Limited
Lunan Pharmaceutical Group Co. Ltd.
Segment by Type
Enflurane
Isoflurane
Halothane
Sevoflurane
Atropine
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhalational Anaesthesia Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inhalational Anaesthesia Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enflurane
1.2.3 Isoflurane
1.2.4 Halothane
1.2.5 Sevoflurane
1.2.6 Atropine
1.3 Market by Application
1.3.1 Global Inhalational Anaesthesia Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inhalational Anaesthesia Drugs Market Perspective (2019-2030)
2.2 Inhalational Anaesthesia Drugs Growth Trends by Region
2.2.1 Global Inhalational Anaesthesia Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Inhalational Anaesthesia Drugs Historic Market Size by Region (2019-2024)
2.2.3 Inhalational Anaesthesia Drugs Forecasted Market Size by Region (2025-2030)
2.3 Inhalational Anaesthesia Drugs Market Dynamics
2.3.1 Inhalational Anaesthesia Drugs Industry Trends
2.3.2 Inhalational Anaesthesia Drugs Market Drivers
2.3.3 Inhalational Anaesthesia Drugs Market Challenges
2.3.4 Inhalational Anaesthesia Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inhalational Anaesthesia Drugs Players by Revenue
3.1.1 Global Top Inhalational Anaesthesia Drugs Players by Revenue (2019-2024)
3.1.2 Global Inhalational Anaesthesia Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Inhalational Anaesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inhalational Anaesthesia Drugs Revenue
3.4 Global Inhalational Anaesthesia Drugs Market Concentration Ratio
3.4.1 Global Inhalational Anaesthesia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inhalational Anaesthesia Drugs Revenue in 2023
3.5 Inhalational Anaesthesia Drugs Key Players Head office and Area Served
3.6 Key Players Inhalational Anaesthesia Drugs Product Solution and Service
3.7 Date of Enter into Inhalational Anaesthesia Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inhalational Anaesthesia Drugs Breakdown Data by Type
4.1 Global Inhalational Anaesthesia Drugs Historic Market Size by Type (2019-2024)
4.2 Global Inhalational Anaesthesia Drugs Forecasted Market Size by Type (2025-2030)
5 Inhalational Anaesthesia Drugs Breakdown Data by Application
5.1 Global Inhalational Anaesthesia Drugs Historic Market Size by Application (2019-2024)
5.2 Global Inhalational Anaesthesia Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Inhalational Anaesthesia Drugs Market Size (2019-2030)
6.2 North America Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Inhalational Anaesthesia Drugs Market Size by Country (2019-2024)
6.4 North America Inhalational Anaesthesia Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inhalational Anaesthesia Drugs Market Size (2019-2030)
7.2 Europe Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Inhalational Anaesthesia Drugs Market Size by Country (2019-2024)
7.4 Europe Inhalational Anaesthesia Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inhalational Anaesthesia Drugs Market Size (2019-2030)
8.2 Asia-Pacific Inhalational Anaesthesia Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inhalational Anaesthesia Drugs Market Size (2019-2030)
9.2 Latin America Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Inhalational Anaesthesia Drugs Market Size by Country (2019-2024)
9.4 Latin America Inhalational Anaesthesia Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inhalational Anaesthesia Drugs Market Size (2019-2030)
10.2 Middle East & Africa Inhalational Anaesthesia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Detail
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. Inhalational Anaesthesia Drugs Introduction
11.1.4 AbbVie Inc. Revenue in Inhalational Anaesthesia Drugs Business (2019-2024)
11.1.5 AbbVie Inc. Recent Development
11.2 Baxter
11.2.1 Baxter Company Detail
11.2.2 Baxter Business Overview
11.2.3 Baxter Inhalational Anaesthesia Drugs Introduction
11.2.4 Baxter Revenue in Inhalational Anaesthesia Drugs Business (2019-2024)
11.2.5 Baxter Recent Development
11.3 Hikma Pharmaceuticals PLC
11.3.1 Hikma Pharmaceuticals PLC Company Detail
11.3.2 Hikma Pharmaceuticals PLC Business Overview
11.3.3 Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Introduction
11.3.4 Hikma Pharmaceuticals PLC Revenue in Inhalational Anaesthesia Drugs Business (2019-2024)
11.3.5 Hikma Pharmaceuticals PLC Recent Development
11.4 Halocarbon Products Corporation
11.4.1 Halocarbon Products Corporation Company Detail
11.4.2 Halocarbon Products Corporation Business Overview
11.4.3 Halocarbon Products Corporation Inhalational Anaesthesia Drugs Introduction
11.4.4 Halocarbon Products Corporation Revenue in Inhalational Anaesthesia Drugs Business (2019-2024)
11.4.5 Halocarbon Products Corporation Recent Development
11.5 Piramal Enterprises Limited
11.5.1 Piramal Enterprises Limited Company Detail
11.5.2 Piramal Enterprises Limited Business Overview
11.5.3 Piramal Enterprises Limited Inhalational Anaesthesia Drugs Introduction
11.5.4 Piramal Enterprises Limited Revenue in Inhalational Anaesthesia Drugs Business (2019-2024)
11.5.5 Piramal Enterprises Limited Recent Development
11.6 Lunan Pharmaceutical Group Co. Ltd.
11.6.1 Lunan Pharmaceutical Group Co. Ltd. Company Detail
11.6.2 Lunan Pharmaceutical Group Co. Ltd. Business Overview
11.6.3 Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Introduction
11.6.4 Lunan Pharmaceutical Group Co. Ltd. Revenue in Inhalational Anaesthesia Drugs Business (2019-2024)
11.6.5 Lunan Pharmaceutical Group Co. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Inhalational Anaesthesia Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Enflurane
Table 3. Key Players of Isoflurane
Table 4. Key Players of Halothane
Table 5. Key Players of Sevoflurane
Table 6. Key Players of Atropine
Table 7. Global Inhalational Anaesthesia Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Inhalational Anaesthesia Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Inhalational Anaesthesia Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Inhalational Anaesthesia Drugs Market Share by Region (2019-2024)
Table 11. Global Inhalational Anaesthesia Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Inhalational Anaesthesia Drugs Market Share by Region (2025-2030)
Table 13. Inhalational Anaesthesia Drugs Market Trends
Table 14. Inhalational Anaesthesia Drugs Market Drivers
Table 15. Inhalational Anaesthesia Drugs Market Challenges
Table 16. Inhalational Anaesthesia Drugs Market Restraints
Table 17. Global Inhalational Anaesthesia Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Inhalational Anaesthesia Drugs Market Share by Players (2019-2024)
Table 19. Global Top Inhalational Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalational Anaesthesia Drugs as of 2023)
Table 20. Ranking of Global Top Inhalational Anaesthesia Drugs Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Inhalational Anaesthesia Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Inhalational Anaesthesia Drugs Product Solution and Service
Table 24. Date of Enter into Inhalational Anaesthesia Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Inhalational Anaesthesia Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Inhalational Anaesthesia Drugs Revenue Market Share by Type (2019-2024)
Table 28. Global Inhalational Anaesthesia Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Inhalational Anaesthesia Drugs Revenue Market Share by Type (2025-2030)
Table 30. Global Inhalational Anaesthesia Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Inhalational Anaesthesia Drugs Revenue Market Share by Application (2019-2024)
Table 32. Global Inhalational Anaesthesia Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Inhalational Anaesthesia Drugs Revenue Market Share by Application (2025-2030)
Table 34. North America Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Inhalational Anaesthesia Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Inhalational Anaesthesia Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Inhalational Anaesthesia Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Inhalational Anaesthesia Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Inhalational Anaesthesia Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Inhalational Anaesthesia Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Inhalational Anaesthesia Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Inhalational Anaesthesia Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Inhalational Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Inhalational Anaesthesia Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 49. AbbVie Inc. Company Detail
Table 50. AbbVie Inc. Business Overview
Table 51. AbbVie Inc. Inhalational Anaesthesia Drugs Product
Table 52. AbbVie Inc. Revenue in Inhalational Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 53. AbbVie Inc. Recent Development
Table 54. Baxter Company Detail
Table 55. Baxter Business Overview
Table 56. Baxter Inhalational Anaesthesia Drugs Product
Table 57. Baxter Revenue in Inhalational Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 58. Baxter Recent Development
Table 59. Hikma Pharmaceuticals PLC Company Detail
Table 60. Hikma Pharmaceuticals PLC Business Overview
Table 61. Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Product
Table 62. Hikma Pharmaceuticals PLC Revenue in Inhalational Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 63. Hikma Pharmaceuticals PLC Recent Development
Table 64. Halocarbon Products Corporation Company Detail
Table 65. Halocarbon Products Corporation Business Overview
Table 66. Halocarbon Products Corporation Inhalational Anaesthesia Drugs Product
Table 67. Halocarbon Products Corporation Revenue in Inhalational Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 68. Halocarbon Products Corporation Recent Development
Table 69. Piramal Enterprises Limited Company Detail
Table 70. Piramal Enterprises Limited Business Overview
Table 71. Piramal Enterprises Limited Inhalational Anaesthesia Drugs Product
Table 72. Piramal Enterprises Limited Revenue in Inhalational Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 73. Piramal Enterprises Limited Recent Development
Table 74. Lunan Pharmaceutical Group Co. Ltd. Company Detail
Table 75. Lunan Pharmaceutical Group Co. Ltd. Business Overview
Table 76. Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Product
Table 77. Lunan Pharmaceutical Group Co. Ltd. Revenue in Inhalational Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 78. Lunan Pharmaceutical Group Co. Ltd. Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inhalational Anaesthesia Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Inhalational Anaesthesia Drugs Market Share by Type: 2023 VS 2030
Figure 3. Enflurane Features
Figure 4. Isoflurane Features
Figure 5. Halothane Features
Figure 6. Sevoflurane Features
Figure 7. Atropine Features
Figure 8. Global Inhalational Anaesthesia Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Inhalational Anaesthesia Drugs Market Share by Application: 2023 VS 2030
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Inhalational Anaesthesia Drugs Report Years Considered
Figure 14. Global Inhalational Anaesthesia Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Inhalational Anaesthesia Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Inhalational Anaesthesia Drugs Market Share by Region: 2023 VS 2030
Figure 17. Global Inhalational Anaesthesia Drugs Market Share by Players in 2023
Figure 18. Global Top Inhalational Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalational Anaesthesia Drugs as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Inhalational Anaesthesia Drugs Revenue in 2023
Figure 20. North America Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Inhalational Anaesthesia Drugs Market Share by Country (2019-2030)
Figure 22. United States Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Inhalational Anaesthesia Drugs Market Share by Country (2019-2030)
Figure 26. Germany Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Inhalational Anaesthesia Drugs Market Share by Region (2019-2030)
Figure 34. China Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Inhalational Anaesthesia Drugs Market Share by Country (2019-2030)
Figure 42. Mexico Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Inhalational Anaesthesia Drugs Market Share by Country (2019-2030)
Figure 46. Turkey Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Inhalational Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. AbbVie Inc. Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2019-2024)
Figure 49. Baxter Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2019-2024)
Figure 50. Hikma Pharmaceuticals PLC Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2019-2024)
Figure 51. Halocarbon Products Corporation Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2019-2024)
Figure 52. Piramal Enterprises Limited Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2019-2024)
Figure 53. Lunan Pharmaceutical Group Co. Ltd. Revenue Growth Rate in Inhalational Anaesthesia Drugs Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
